Oncology PracticeSafe to expand limits of active surveillance in thyroid cancer?October 27, 2022Head & Neck/Thyroid Cancers
Oncology PracticeChildren with low-risk thyroid cancer can skip radioactive iodineOctober 27, 2022PediatricsHead & Neck/Thyroid Cancers
Oncology PracticeAnalysis suggests an ‘urgent need’ for personalized head and neck cancer follow-upOctober 21, 2022Head & Neck/Thyroid Cancers
Oncology PracticeWhen cisplatin won’t do, try carboplatin in head and neck cancerOctober 6, 2022Head & Neck/Thyroid Cancers
Oncology PracticeIs early-onset cancer an emerging global epidemic?October 5, 2022Preventive CareBreast CancerHead & Neck/Thyroid CancersGastrointestinal CancerGenitourinary CancerRenal Cell Carcinoma
Oncology PracticeCancer as a full contact sportOctober 3, 2022Patient & Survivor CarePractice ManagementRenal Cell CarcinomaMetastatic Breast CancerMixed TopicsMelanomaLung Cancer
Oncology PracticeDespite benefits, extended-interval pembro uptake remains lowSeptember 28, 2022Lung CancerHead & Neck/Thyroid CancersMelanomaGastrointestinal CancerGenitourinary Cancer
Oncology PracticeNeoadjuvant immunotherapy shows promise for resectable CSCCSeptember 27, 2022Head & Neck/Thyroid Cancers
Oncology PracticeFDA OKs selpercatinib for adults with RET-fusion+ solid tumorsSeptember 23, 2022Lung CancerHead & Neck/Thyroid CancersGastrointestinal CancerMetastatic Breast Cancer
Oncology PracticeHigh BMI linked to better survival for cancer patients treated with ICI, but for men onlySeptember 22, 2022Lung CancerBreast CancerGastrointestinal CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid CancersMetastatic Breast Cancer
Oncology PracticeA farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022Gastrointestinal CancerPractice ManagementMixed TopicsBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic Cancer
Oncology PracticeTime to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
Oncology PracticePembro/chemo combo fails to improve event-free survival in head and neck cancerSeptember 14, 2022Head & Neck/Thyroid Cancers
Oncology PracticeFirst drug for desmoid tumors: ‘Impressive’ data for nirogacestatSeptember 13, 2022Gastrointestinal CancerHead & Neck/Thyroid Cancers
Oncology PracticeNearly 30% of U.S. cancer deaths linked to smokingAugust 30, 2022Lung CancerPreventive CareHead & Neck/Thyroid Cancers
